Opioid Withdrawal Treatment Market 2021 By Emerging Trends, Industry Share, Regional Overview and SWOT Analysis till 2028
Market Overview
Market
Research Future (MRFR) expects the Opioid Withdrawal Treatment Market to gain a decent CAGR of 10.1% from 2020
to 2027 (evaluation period).
Get
Sample Report: https://www.marketresearchfuture.com/sample_request/8123
Primary Boosters and Challenges
The
American Society of Addiction Medicine reveals that around 3 million Americans
in 2015 battled addiction to opioid (either prescription painkillers or heroin).
Over 60 percent of deaths that same year involved some type of opioid, suggests
the Centers for Disease Control and Prevention studies. These numbers indicate
the urgent need to bring down the number of overdose cases, ultimately
fostering the demand for opioid withdrawal treatment. Opioids are also used for
curing anxiety and depression, which are some of the most common mental health
issues around the world. Currently, the primary focus is on curbing the
wrongful use of opioids, and therefore, effective, and more innovative withdrawal
treatment lines are increasingly being developed by government bodies, companies
as well as the healthcare industry. Healthcare practitioners are now highly vocal
regarding drug peddlers and trying to create more awareness among the youth
which should foster significant market growth in the ensuing years.
Rehabilitation
centers are progressively being set up across the globe for the treatment of
individuals struggling with opioid withdrawal symptoms. More and more patients
are opting for these rehab centers to quit opioids, which could be a major
growth booster in the global market. Moreover, the need to create a balanced
life for every section of the society has fostered the demand for the opioid
withdrawal treatment market. Other growth rendering factors include technological
innovations in the diagnostics sector, soaring awareness among patients about the
available treatment options and the surge in treatment rates as well as improving
healthcare infrastructure.
Market Segmentation
To
present a detailed outline of the global opioid withdrawal treatment industry,
MRFR report has profiled a few key segments, namely drug type as well as distribution
channel.
The
major drug types considered in the report are anti-nausea medications,
nonsteroidal anti-inflammatory drugs, natural sleep supplements, analgesics,
and others.
With
respect to distribution channel, the global market can be considered for retail
pharmacies, online stores, and hospital pharmacy. The lead has been secured by
the hospital pharmacies segment, since hospitals note significant number of patient
visits compared to other healthcare facilities. As a result, maximum sales of
opioid withdrawal drugs take place at hospital pharmacies, especially given the
availability of a prescription by the doctor.
Eminent Firms
Merck
& Co., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novartis, Sanofi,
Johnson & Johnson Services, Hoffmann-La Roche Ltd, Bayer AG, are some of the most eminent vendors in the
global market for opioid withdrawal treatment.
Regional
Status
Asia
Pacific/APAC, Americas, MEA or Middle East & Africa and Europe are the
primary markets for opioid withdrawal treatment worldwide.
The
Americas is spearheading the global market, in view of the soaring number of drug
awareness campaigns as well as prevention programs. These campaigns cover
spreading awareness among patients to boost the treatment-seeking rate. Rising government
intervention with significant funds and initiatives to control distribution of
illicit drugs and other substances also favor the regional market. Other growth
enhancing factors include burgeoning population of substance abusers, the surge
in technical advancements and the expanding geriatric populace.
Asia
Pacific shows the potential to attain the fastest growth rate in the years to
come, thanks to the growing efforts by several countries to deal with mounting
concerns regarding drug and alcohol abuse. Moreover, government across various
countries are spending considerably on promotional campaigns to prevent and
treat addiction. The rise in technical advances also elevate the market
position in the region. Opioid abuse is significantly rampant in the region,
especially among the lower-class population while mental health issues have
become major concerns. This is bound to create a lucrative scenario for the
opioid withdrawal treatment market in the following years. Also, given the lower
clinical trials costs, global companies are focusing on setting up their
manufacturing bases in Singapore, Japan, China, Australia and Korea, which could
mean substantial revenue generation in the near future.
Latest News
·
March
2021
Atai
Life Sciences and DemeRx have received the go ahead from the UK Medicines and
Healthcare products Regulatory Agency/MHRA to start enrolling for their Phase I
and II analysis of ibogaine HCl, for treating opioid use disorder. Atai Life
Sciences has spent around USD 22 million in this joint venture for developing
the psychedelic, which has been proven to be effective and efficacious for the
treatment of OUD.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/opioid-withdrawal-treatment-market-8123
About
US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson
Street,5Th Floor, New York,
New York
10013
Related Reports: Hyperhidrosis
Treatment Market Research Report - Global Forecast till 2027
Global
Healthcare Data Storage Market Research Report—Forecast till 2027
Comments
Post a Comment